Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2001

View Archived Issues

Second-quarter progress reported in Sanochemia projects

Synthetic peptide bundles F-actin in vitro and in situ; available for licensing

KW-7158 to enter phase II trials in Europe for treatment of urinary incontinence

Gilead presents data characterizing resistance profile of tenofovir DF

Antares Pharma delivery technology utilized in new testosterone gel for FSD

GM-611 improves delayed gastric emptying in patients with gastroparesis

DDW presentation reports rapid vascular shutdown in tumor-bearing rats treated with AC-7700

Zomig-ZMT now available in U.S. for treatment of migraine

MedImmune expands phase II development of MEDI-507 to include Europe

Prostanoid EP1 antagonist ZD-6416 as a novel therapy for common painful disorder

Preliminary phase I data for Revimid show activity against solid tumors, good safety

Bone loss and turnover inhibited by lasofoxifene in OVX primates, without uterine hypertrophy

Guilford's sNDA for Gliadel Wafer accepted by FDA

IBMS/ECTS 2001 news: FC-1271a is a promising new SERM for postmenopausal women

Viragen and NIH begin preclinical studies of anti-Notch-1 monoclonal antibodies

FDA advisory committee votes in favor of Xyrem's efficacy for cataplexy

New bisphosphonate inhibits two enzymes in the mevalonate pathway

Phytopharmaceutical DA-9601 prevents development of pancreatic fibrosis

ConjuChem highlights Q2 developments

Somatostatin-mediated targeting of DNA into tumor cells

NOD2 mutants associated with Crohn's disease

Cannabinoids a focus of research at U. of Connecticut

Novel Taisho compounds useful for immune and allergic disorders

Microtubule polymerization enhancers for cancer patented by Novartis and Scripps

Pyridine-based inhibitors of collagen production emerge from R&D at Otsuka

Aventis presents new series of anticoagulant/antithrombotic compounds

New 2-alkoxybenzene tachykinin antagonists from Sankyo with good oral activity

Derivatives of UCS-1025 synthesized at Kyowa Hakko with antibacterial and antitumor activity